ZDHHC7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.204600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.447000E-01
Normal-vs-Stage2
2.567600E-01
Normal-vs-Stage3
5.440600E-01
Normal-vs-Stage4
6.253800E-02
Stage1-vs-Stage2
1.309570E-01
Stage1-vs-Stage3
4.983600E-01
Stage1-vs-Stage4
3.450500E-02
Stage2-vs-Stage3
8.292200E-01
Stage2-vs-Stage4
1.544010E-01
Stage3-vs-Stage4
4.010400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.395000E-01
Normal-vs-AfricanAmerican
5.714800E-01
Normal-vs-Asian
2.970800E-01
Caucasian-vs-AfricanAmerican
4.926000E-01
Caucasian-vs-Asian
4.475000E-01
AfricanAmerican-vs-Asian
3.567600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.518000E-01
Normal-vs-Female
2.901600E-01
Male-vs-Female
8.614200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.518800E-01
Normal-vs-Age(41-60Yrs)
1.957570E-01
Normal-vs-Age(61-80Yrs)
3.883800E-01
Normal-vs-Age(81-100Yrs)
3.082800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.064800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.081400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.627800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.121400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.196400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.049800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.476400E-01
Normal-vs-Daily Drinker
4.168800E-01
Normal-vs-Weekly Drinker
3.711800E-01
Normal-vs-Occasional Drinker
9.581900E-02
Normal-vs-Social Drinker
4.063400E-01
Non Drinker-vs-Daily Drinker
9.939800E-01
Non Drinker-vs-Weekly Drinker
6.303200E-01
Non Drinker-vs-Occasional Drinker
9.629500E-02
Non Drinker-vs-Social Drinker
7.979200E-01
Daily Drinker-vs-Weekly Drinker
6.808000E-01
Daily Drinker-vs-Occasional Drinker
1.505160E-01
Daily Drinker-vs-Social Drinker
8.195800E-01
Weekly Drinker-vs-Occasional Drinker
4.255800E-01
Weekly Drinker-vs-Social Drinker
5.540200E-01
Occasional Drinker-vs-Social Drinker
9.663900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.794200E-01
Normal-vs-Grade 2
2.690000E-02
Normal-vs-Grade 3
2.765600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.383200E-04
Grade 1-vs-Grade 3
1.081790E-03
Grade 1-vs-Grade 4
2.794200E-01
Grade 2-vs-Grade 3
9.583200E-01
Grade 2-vs-Grade 4
2.690000E-02
Grade 3-vs-Grade 4
2.765600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.208800E-01
Normal-vs-NonDiabetic
2.889200E-01
Diabetic-vs-NonDiabetic
4.200800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.616100E-02
Normal-vs-NoPancreatitis
3.514200E-01
Pancreatitis-vs-NoPancreatitis
1.196570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.384600E-01
Normal-vs-N1
2.839200E-01
N0-vs-N1
8.639400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.27700000000098E-05
Normal-vs-TP53-NonMutant
1.440390E-01
TP53-Mutant-vs-TP53-NonMutant
1.2571999999933E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
